Click Here for 5% Off Your First Aladdin Purchase!

(R)-CPP - ≥95%, high purity , CAS No.126453-07-4

  • ≥95%
Item Number
C274937
Grouped product items
SKUSizeAvailabilityPrice Qty
C274937-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$149.90
C274937-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$599.90
C274937-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,119.90

Potent NMDA antagonist

View related series
Antagonists iGluR

Basic Description

Synonyms(R)-4-(3-phosphonopropyl)piperazine-2-carboxylic acid | (2R)-4-(3-phosphonopropyl)piperazine-2-carboxylic acid
Specifications & Purity≥95%
Biochemical and Physiological MechanismsHighly potent, competitive NMDA antagonist; more active enantiomer of ( RS )-CPP . (K i values are 0.04 (NR1/NR2A), 0.3 (NR1/NR2B), 0.6 (NR1/NR2C) and 2.0 μM (NR1/NR2D)).
Storage TempStore at -20°C,Desiccated
Shipped InIce chest + Ice pads
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Associated Targets

CYP1A2 Tchem Cytochrome P450 1A2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2D6 Tclin Cytochrome P450 2D6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2C19 Tchem Cytochrome P450 2C19 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A4 Tclin Cytochrome P450 3A4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2C9 Tchem Cytochrome P450 2C9 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HSD17B10 Tchem 3-hydroxyacyl-CoA dehydrogenase type-2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ALOX15 Tchem Arachidonate 15-lipoxygenase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM1 Tclin Muscarinic acetylcholine receptor M1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

THRB Tclin Thyroid hormone receptor beta 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GRIA3 Tclin Glutamate receptor 3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GRIN3A Tclin Glutamate receptor ionotropic, NMDA 3A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GRIN1 Tclin Glutamate receptor ionotropic, NMDA 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (2R)-4-(3-phosphonopropyl)piperazine-2-carboxylic acid
INCHI InChI=1S/C8H17N2O5P/c11-8(12)7-6-10(4-2-9-7)3-1-5-16(13,14)15/h7,9H,1-6H2,(H,11,12)(H2,13,14,15)/t7-/m1/s1
InChi Key CUVGUPIVTLGRGI-SSDOTTSWSA-N
Canonical SMILES C1CN(CC(N1)C(=O)O)CCCP(=O)(O)O
Isomeric SMILES C1CN(C[C@@H](N1)C(=O)O)CCCP(=O)(O)O
PubChem CID 6603754
Molecular Weight 252.21

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilitySoluble in water to 100 mM

Related Documents

Alternative Products

References

1. Belhassen B & Motté G.  (1979)  [Intranodal reciprocal dual rhythm]..  Arch Mal Coeur Vaiss,  72  (12): (1395-401).  [PMID:120159]
2. Hedrick T & Waters J.  (2015)  Acetylcholine excites neocortical pyramidal neurons via nicotinic receptors..  J Neurophysiol,  113  (7): (2195-209).  [PMID:25589590]
3. Pugh JR & Jahr CE.  (2013)  Activation of axonal receptors by GABA spillover increases somatic firing..  J Neurosci,  33  (43): (16924-9).  [PMID:24155298]
4. Pugh JR & Jahr CE.  (2011)  Axonal GABAA receptors increase cerebellar granule cell excitability and synaptic activity..  J Neurosci,  31  (2): (565-74).  [PMID:21228165]
5. Turecek J & Regehr WG.  (2020)  Cerebellar and vestibular nuclear synapses in the inferior olive have distinct release kinetics and neurotransmitters..  Elife,    [PMID:33259288]
6. Rudolph S et al..  (2020)  Cerebellum-Specific Deletion of the GABAA Receptor d Subunit Leads to Sex-Specific Disruption of Behavior..  Cell Rep,  33  (5): (108338).  [PMID:33147470]
7. Herman MA et al..  (2011)  Distribution of extracellular glutamate in the neuropil of hippocampus..  PLoS One,  (11): (e26501).  [PMID:22069455]
8. Chanda S & Xu-Friedman MA.  (2011)  Excitatory modulation in the cochlear nucleus through group I metabotropic glutamate receptor activation..  J Neurosci,  31  (20): (7450-5).  [PMID:21593328]
9. Bagnall MW et al..  (2009)  Glycinergic projection neurons of the cerebellum..  J Neurosci,  29  (32): (10104-10).  [PMID:19675244]
10. Winland CD et al..  (2017)  Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons..  Eur J Neurosci,  46  (9): (2519-2533).  [PMID:28921719]
11. Balmer TS et al..  (2021)  Incomplete removal of extracellular glutamate controls synaptic transmission and integration at a cerebellar synapse..  Elife,  10    [PMID:33616036]
12. Qi Y et al..  (2014)  Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents..  Acta Neuropathol Commun,  (175).  [PMID:25540024]
13. Khan MM & Regehr WG.  (2020)  Loss of Doc2b does not influence transmission at Purkinje cell to deep nuclei synapses under physiological conditions..  Elife,    [PMID:32347796]
14. Young MB & Thomas SA.  (2014)  M1-muscarinic receptors promote fear memory consolidation via phospholipase C and the M-current..  J Neurosci,  34  (5): (1570-8).  [PMID:24478341]
15. Vaden RJ et al..  (2020)  Parvalbumin interneurons provide spillover to newborn and mature dentate granule cells..  Elife,    [PMID:32602839]
16. Babola TA et al..  (2021)  Purinergic Signaling Controls Spontaneous Activity in the Auditory System throughout Early Development..  J Neurosci,  41  (4): (594-612).  [PMID:33303678]
17. Guo C et al..  (2021)  Purkinje cell outputs selectively inhibit a subset of unipolar brush cells in the input layer of the cerebellar cortex..  Elife,  10    [PMID:34369877]
18. Apostolides PF & Trussell LO.  (2013)  Rapid, activity-independent turnover of vesicular transmitter content at a mixed glycine/GABA synapse..  J Neurosci,  33  (11): (4768-81).  [PMID:23486948]
19. Bock R et al..  (2013)  Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use..  Nat Neurosci,  16  (5): (632-8).  [PMID:23542690]
20. Tang ZQ & Trussell LO.  (2015)  Serotonergic regulation of excitability of principal cells of the dorsal cochlear nucleus..  J Neurosci,  35  (11): (4540-51).  [PMID:25788672]
21. Burke DA & Alvarez VA.  (2022)  Serotonin receptors contribute to dopamine depression of lateral inhibition in the nucleus accumbens..  Cell Rep,  39  (6): (110795).  [PMID:35545050]

Solution Calculators